Alexander Gebauer, a pharmacologist and physician, has joined the management board of Omeicos Therapeutics in Germany to oversee the clinical development of the company’s lead product for atrial fibrillation. He has also been named chief executive and chairman of the board of the company’s recently founded US subsidiary Omeicus Ophthalmics.
Dr Gebauer has held executive positions at Hoechst AG, Merz Pharmaceuticals and Ranbaxy Laboratories Ltd. He studied medicine at Johann Gutenberg University in Mainz, Germany where he completed his thesis in pharmacology.
Omeicos Therapeutics announced the appointment on 27 April 2018.
Copyright 2018 Evernow Publishing Ltd.